David Morley PhD

Vice President
Computational Technology
Ariana Pharma
France

Business Expert Oncology
Biography

  Dr. Morley has the overall responsibility for the computational technologies at the heart of Ariana and has been involved with the KEM® technology from its inception to today. Dave is an experienced computational technologist with a 20 year track record in the development of high-performance machine learning solutions to “big data” scientific challenges across multiple industries, including pharma, chemical and finance. At RiboTargets (Cambridge, UK) he was the architect and project manager of RiboDock/rDock, a production virtual screening platform for structure-based drug discovery. Through his own consultancy business he has also delivered innovative software applications for GSK, Vernalis and Hyde Park Global Investments. Dr. Morley has a PhD in Computational Chemistry from the University of Nottingham and a BSc Hons (First Class) in Chemistry from the University of Bristol.

Research Intrest

Computational Chemistry